期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

膀胱灌注预防膀胱肿瘤复发:长疗程是必要的 被引量：10

暂未订购
导出
摘要 非肌层浸润性膀胱癌（non-muscle—invasive bladder cancer，NMIBC）（即Ta、T1及CIS膀胱癌）行经尿道膀胱肿瘤切除（transurethral resection of bladder tumor，TUR）术后，主要临床特点为复发风险高，其次为疾病进展。为了预防肿瘤复发和进展风险，目前比较公认的是，NMIBC的标准治疗是TUR术后辅以膀胱灌注化疗或免疫治疗。
作者 兰卫华
机构地区 第三军医大学大坪医院野战外科研究所泌尿外科
出处 《现代泌尿外科杂志》 CAS 2013年第3期285-287,共3页 Journal of Modern Urology
关键词 膀胱肿瘤 膀胱灌注 长疗程
分类号 R737.1 [医药卫生—肿瘤]
  • 相关文献

参考文献11

  • 1BABJUK M, OOSTERLINCK W,SYLVESTER R,et al.EAU guidelines on nonmuscleinvasive urothelial carcinoma of the bladder,the 2011 update[J].Eur Urol,2011,59(6):997-1008..
  • 2HALL MC, CHANG SS,DALBAGNI G,et al.Guideline for the management of nonmuscle invasive bladder cancer (stages Ta,T1,and Tis):2007 up date[J].J Urol,2007,178(6):2314-2330.
  • 3GRIFFITHS TR. On behalf of Action on Bladder Cancer (Charity Registration Number:1138532).Current perspectives in bladder cancer management[J/OL].Int J Clin Pract.2012 Nov 9.doi:101111/ijcp.12075.[Epub ahead of print].
  • 4BOUFFIOUX C, KURTH KH,BONO A,et al.Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma:results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxorubicin comparing early versus delayed instillations and shortterm versus longterm treatment.European Organization for Research and Treatment of Cancer Genitourinary Group[J].J Urol,1995,153(3 Pt 2):934-941..
  • 5ISBARN H, BUDUS L,PICHLMEIER U,et al.Comparison of the effectiveness between longterm instillation of mitomycin C and shortterm prophylaxis with MMC or bacille CalmetteGuérin.Study of patients with nonmuscleinvasive urothelial cancer of the urinary bladder(Article in German)[J].Urologe A,2008,47(5):608-615..
  • 6ODDENS J, BRAUSI M,SYLVESTER R,et al.Final results of an EORTCGU Cancers Group randomized study of maintenance Bacillus CalmetteGuérin in intermediate and highrisk Ta,T1 papillary carcinoma of the urinary bladder:Onethird dose versus full dose and 1 year versus 3 years of maintenance[J/OL].Eur Urol,2012 Nov 2.pii:S03022838(12)012705.doi:101016/j.eururo.2012.10- 039.[Epub ahead of print]..
  • 7张尧,兰卫华,王洛夫,靳风烁.卡介苗膀胱灌注维持与非维持疗法治疗浅表膀胱癌:关于预防复发和进展疗效比较Meta分析[J].循证医学,2008,8(5):284-288. 被引量：3
  • 8VAN DER MEIJDEN AP,SYLVESTER RJ,OOSTERLINCK W,et al.Maintenance Bacillus CalmetteGuerin for Ta T1 bladder tumors is not associated with increased toxicity:results from a European organisation for research and treatment of cancer Genitourinary group phase Ⅲ trial[J].Eur Urol,2003,44(4):429-434..
  • 9MARTíNEZPIEIRO JA,FLORES N,ISORNA S,et al.Longterm followup of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille CalmetteGuérin with a reduced dose of 27 mg in superficial bladder cancer[J].BJU Int,2002,89(7):671-680.
  • 10MARTíNEZPIEIRO JA,MARTíNEZPIEIRO L,SOLSONA E,et al.Has a 3fold decreased dose of bacillus CalmetteGuerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial[J].J Urol,2005,174(4 Pt 1):1242-1247..

二级参考文献13

  • 1兰卫华,靳风烁,王洛夫,谢芳,王晶.卡介苗与丝裂霉素C膀胱灌注预防浅表性膀胱癌复发疗效及毒性比较的Meta分析[J].中华泌尿外科杂志,2006,27(1):29-32. 被引量：36
  • 2Bohle A, Jocham D, Bock PR. Intravesical bacillus Calmette- Guerin versus Mitomycin C for superficial bladder cancer: A formal meta-analysis of comparative studies on recurrence and toxicity [J]. J Urol, 2003,169:90-95.
  • 3Bohle A, Bock PR. Intravesical bacille Calmette-Guerin versus Mitomycin C in superficial bladder cancer: Formal meta-analysis of comparative studies on tumor progression [J]. Urology, 2004,63 : 682-686.
  • 4Badalament RA, Herr HW, Wong GY, et al. A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guerin therapy of superficial bladder cancer [J]. J Clin Oncol, 1987,5:441-449.
  • 5Hudson MA, Ratliff TL, Gillen DP, et al. Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors:A prospective, randomized trial [J]. J Urol, 1987,138:295-298.
  • 6Yabusaki N, Komatsu H, Tago K, et al. Intravesical instillation of bacillus Calmette-Guerin for superficial bladder carcinoma: Study on significance of additional maintenance instillations of bacillus Calmette-Guerin [J]. Nippon Hinyokika Gakkai Zasshi, 1991,82:290-296.
  • 7Akaza H, Hinotsu S, Aso Y, et al. Bacillus Calmette-Guerin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder. Four-year results. The Bladder Cancer BCG Study Group [ J ]. Cancer, 1995,75 : 552-559.
  • 8Gruenwald IE, Stein A, Rashcovitsky R, et al. A 12 versus 6- week course of bacillus Calmette-Guerin prophylaxis for the treatment of high risk superficial bladder cancer [J]. J Urol, 1997,157 : 487-491
  • 9Lamm DL, Blumenstein BA, Crissman JD, et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study [J]. J Urol, 2000,163 : 1124-1129.
  • 10Palou P, Laguna P, Millan-Rodriguez F, et al. Control group and maintenance treatment with bacillus Calmette-Guerin for carcinoma in situ and/or high grade bladder tumors [J]. J Urol, 2001,165 : 1488-1491.

共引文献2

同被引文献76

引证文献10

二级引证文献132

现代泌尿外科杂志
2013年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部